Ginkgo Bioworks Holdings (DNA) Gross Profit (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has reported Gross Profit for 7 consecutive years, with $18.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit fell 45.38% year-over-year to $18.4 million; the trailing twelve-month figure through Jun 2026 stood at $92.9 million (down 49.29% YoY), and the FY2025 full-year result was $138.6 million, down 26.45% from the prior year.
• Gross Profit grew to $18.4 million in Q2 2026 per DNA's latest filing, from $16.4 million in the prior quarter.
• Across five years, Gross Profit topped out at $244.0 million in Q4 2023 and bottomed at $16.4 million in Q1 2026.
• Historically, Gross Profit has averaged $59.3 million across 5 years, with a median of $43.1 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Gross Profit soared 200.24% in 2022, then tumbled 85.12% in 2024.
• Over 5 years, Gross Profit stood at $88.7 million in 2022, then soared by 174.99% to $244.0 million in 2023, then sank by 85.12% to $36.3 million in 2024, then slipped by 24.36% to $27.5 million in 2025, then sank by 32.84% to $18.4 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $18.4 million, $16.4 million, and $27.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.